abstract |
The present invention relates to the use of 3-[4-(2-phenyl-Indol-1-ylmethyl)-phenyl]Acrylamide compounds and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)benzyl]-1H-indol-5-ol compounds which are useful as estrogenic agents, as well as pharmaceutical compositions and methods of treatment utilizing these compounds, the compounds having general formula (I) or (II). |